News | Radiation Therapy | August 03, 2016

National Cancer Institute Leader Talks Cancer Moonshot at AAPM

Spoke to medical physicists, who play key role in cancer diagnosis, treatment

NCI, Cancer Moonshot, radiation therapy

Douglas R. Lowy, M.D., acting director of the National Cancer Institute (NCI).

Providing insights into the Cancer Moonshot and other initiatives to accelerate cancer research and make more therapies available to patients, Douglas R. Lowy, M.D., acting director of the National Cancer Institute (NCI), led a plenary session at the 58th Annual Meeting of the American Association of Physicists in Medicine (AAPM).

Medical physicists play a vital role in the diagnosis and treatment of cancer, through the development of novel imaging techniques, advancement of innovative therapy approaches, and ensuring the clinical use of imaging and radiation therapy are safe and effective. The NCI currently is funding several research initiatives on imaging and radiation therapy to better understand how to use immunotherapies in combination with targeted therapies and treatments such as chemotherapy and radiation.

“As medical physicists, we look forward to exploring ways in which our unique skills in the safe and accurate use of technology and radiation can advance the goals of the Cancer Moonshot,” said Bruce H. Curran, M.Eng., M.S., president of AAPM and associate professor of radiation oncology at VCU Health Systems, Richmond, Va. “We play a vital role as professionals involved not only in helping to treat cancer patients, but improving diagnosis and monitoring the response of cancer therapies during treatment.”

A longtime researcher, Lowy is one of the most highly cited authors in microbiology, and a member of the National Academy of Sciences and the Institute of Medicine. He received the 2007 Federal Employee of the Year Award from the Partnership for Public Service, the 2007 Dorothy P. Landon-American Association for Cancer Research Prize for Translational Cancer Research, the Sabin Gold Medal in 2011 and the National Medal of Technology and Innovation from President Obama in 2014, among others.

Lowy’s research focuses on papillomaviruses and the regulation of normal and neoplastic growth. In the 1980s he identified the oncogenes encoded by papillomaviruses and recently worked on papillomavirus vaccines and its life cycle.

For more information: www.aapm.org/meetings/2016AM

Related Content

Stronger Distribution Networks to Bolster Radiotherapy Patient Positioning Accessories
News | Patient Positioning Radiation Therapy | July 19, 2019
A recent study projects global market revenues for radiotherapy patient positioning accessories will exceed revenues of...
CMS Proposes New Alternative Payment Model for Radiation Oncology
News | Radiation Oncology | July 17, 2019
The Centers for Medicare and Medicaid Services (CMS) issued a proposal for an advanced alternative payment model (APM)...
AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
RaySearch Releases Version 3A of RayCare Oncology Information System
Technology | Oncology Information Management Systems (OIMS) | July 15, 2019
RaySearch has released RayCare 3A, a new version of the next-generation oncology information system (OIS). RayCare is...
Mirion Showcases Instadose2 Wireless Dual Detector Dosimeter at AAPM and AHRA
News | Radiation Dose Management | July 15, 2019
Featuring dual detectors, the Instadose2 dosimeter addresses international requirements for independent deep [Hp(10)]...
Example of an intentionally truncated CT image

Figure 1: Example of an intentionally truncated CT image. The truncation percentage was calculated as the ratio of the patient border touching the field of view to the total patient border (red/(read+blue)). Image courtesy of Qaelum.

Feature | Radiation Dose Management | July 15, 2019 | Niki Fitousi, Ph.D., and An Dedulle
One of the main benefits of a radiation dose management system is the possibility to automatically generate alerts when...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...